Impact of diabetes and obesity on patient outcomes in alcohol-associated liver disease: Analysis of 3 databases
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2025.09.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Hanna Blaney und 10 weiteren Autor:innen. Beteiligte Einrichtung: MedStar Georgetown University Hospital, Medstar Transplant Hepatology Institute, Washington, DC, USA. Hauptthemen laut MEDLINE: Obesity, Liver Diseases, Alcoholic, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND AND AIM: Alcohol and metabolic risk factors have an additive effect on the progression of steatotic liver diseases. The aim of this study is to examine the impact of T2DM and obesity on outcomes in patients with ALD. METHODS AND RESULTS: We performed a retrospective cohort study of US adults with ALD using NHANES (2017-2020), Nationwide Inpatient Sample (2016-2019), and UNOS (2016-2023) databases. In the NHANES database, patients with ALD and T2DM had higher rates of fibrosis defined by FIB-4 ≥2.67 than patients with ALD without T2DM or obesity, and ALD with obesity, with 17.1% vs. 9.8% vs. 2.3%, respectively (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MedStar Georgetown University Hospital, Medstar Transplant Hepatology Institute, Washington, DC, USA.
- Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY, USA.
- Mobile Infirmary Medical Center, Mobile, Alabama, USA.
- Department of Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota, USA; Department of Hepatology, Avera Mckennan University Hospital and Transplant Institute, Sioux Falls, USA.
- Department of Gastroenterology, University of Kansas Medical Center, Kansas, USA.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Förderung
- National Institute on Alcohol Abuse and Alcoholism
- National Institutes of Health
Zitieren
APA
Blaney, H., Zhang, W., Bandhari, P., Elfeki, M., Xie, C., Dunn, W., Wong, R., Younossi, Z., Kuo, Y. F., Kong, M., & Singal, A. (2025). Impact of diabetes and obesity on patient outcomes in alcohol-associated liver disease: Analysis of 3 databases. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.09.020
Vancouver
Blaney H, Zhang W, Bandhari P, Elfeki M, Xie C, Dunn W, et al. Impact of diabetes and obesity on patient outcomes in alcohol-associated liver disease: Analysis of 3 databases. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.09.020
BibTeX
@article{Blaney2025,
author = {Blaney, Hanna and Zhang, Wanyu and Bandhari, Prabha and Elfeki, Mohamed and Xie, Chencheng and Dunn, Winston and Wong, Robert and Younossi, Zobair and Kuo, Yong-Fang and Kong, Maiying and Singal, Ashwani},
title = {Impact of diabetes and obesity on patient outcomes in alcohol-associated liver disease: Analysis of 3 databases},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2025.09.020}
}
EUVIMED